Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers

Tumor-associated p53 mutations endow cells with malignant phenotypes, including chemoresistance. Amyloid-like oligomers of mutant p53 transform this tumor suppressor into an oncogene. However, the composition and distribution of mutant p53 oligomers are unknown and the mechanism involved in the conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedrote, Murilo M., Motta, Michelle F., Ferretti, Giulia D.S., Norberto, Douglas R., Spohr, Tania C.L.S., Lima, Flavia R.S., Gratton, Enrico, Silva, Jerson L., de Oliveira, Guilherme A.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976948/
https://www.ncbi.nlm.nih.gov/pubmed/31981923
http://dx.doi.org/10.1016/j.isci.2020.100820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6976948/
https://www.ncbi.nlm.nih.gov/pubmed/31981923
http://dx.doi.org/10.1016/j.isci.2020.100820

Ejemplares similares